A detailed history of Pro Vise Management Group, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Pro Vise Management Group, LLC holds 12,376 shares of JNJ stock, worth $1.91 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
12,376
Previous 13,488 8.24%
Holding current value
$1.91 Million
Previous $1.97 Million 1.73%
% of portfolio
0.16%
Previous 0.17%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$145.48 - $167.38 $161,773 - $186,126
-1,112 Reduced 8.24%
12,376 $2.01 Million
Q2 2024

Aug 12, 2024

SELL
$144.38 - $157.78 $100,199 - $109,499
-694 Reduced 4.89%
13,488 $1.97 Million
Q1 2024

May 09, 2024

SELL
$155.22 - $162.74 $302,989 - $317,668
-1,952 Reduced 12.1%
14,182 $2.24 Million
Q4 2023

Feb 09, 2024

SELL
$145.6 - $158.88 $1.12 Million - $1.23 Million
-7,711 Reduced 32.34%
16,134 $2.53 Million
Q3 2023

Nov 08, 2023

SELL
$155.75 - $174.48 $2.83 Million - $3.17 Million
-18,151 Reduced 43.22%
23,845 $3.71 Million
Q2 2023

Aug 24, 2023

BUY
$154.35 - $166.11 $596,254 - $641,682
3,863 Added 10.13%
41,996 $6.95 Million
Q1 2023

May 05, 2023

BUY
$151.05 - $180.26 $146,216 - $174,491
968 Added 2.6%
38,133 $5.91 Million
Q4 2022

Feb 09, 2023

BUY
$160.2 - $179.79 $750,857 - $842,675
4,687 Added 14.43%
37,165 $6.57 Million
Q3 2022

Nov 09, 2022

SELL
$161.33 - $179.52 $3.11 Million - $3.46 Million
-19,254 Reduced 37.22%
32,478 $5.31 Million
Q2 2022

Aug 08, 2022

BUY
$168.19 - $186.01 $3.91 Million - $4.33 Million
23,268 Added 81.75%
51,732 $9.18 Million
Q1 2022

Apr 27, 2022

BUY
$158.14 - $179.59 $406,419 - $461,546
2,570 Added 9.93%
28,464 $5.05 Million
Q4 2021

Jan 18, 2022

SELL
$155.93 - $173.01 $203,020 - $225,259
-1,302 Reduced 4.79%
25,894 $4.43 Million
Q3 2021

Oct 20, 2021

BUY
$161.5 - $179.47 $278,264 - $309,226
1,723 Added 6.76%
27,196 $4.39 Million
Q2 2021

Aug 06, 2021

SELL
$159.48 - $171.07 $194,884 - $209,047
-1,222 Reduced 4.58%
25,473 $4.2 Million
Q1 2021

Apr 22, 2021

SELL
$153.07 - $170.48 $57,248 - $63,759
-374 Reduced 1.38%
26,695 $4.39 Million
Q4 2020

Jan 19, 2021

BUY
$137.11 - $157.38 $112,704 - $129,366
822 Added 3.13%
27,069 $4.26 Million
Q3 2020

Oct 26, 2020

BUY
$140.38 - $153.83 $130,413 - $142,908
929 Added 3.67%
26,247 $3.91 Million
Q2 2020

Aug 07, 2020

BUY
$128.81 - $155.51 $62,601 - $75,577
486 Added 1.96%
25,318 $3.56 Million
Q1 2020

May 07, 2020

SELL
$111.14 - $153.99 $3.48 Million - $4.83 Million
-31,335 Reduced 55.79%
24,832 $3.26 Million
Q4 2019

Feb 11, 2020

SELL
$127.5 - $146.44 $81,472 - $93,575
-639 Reduced 1.12%
56,167 $8.19 Million
Q3 2019

Nov 13, 2019

SELL
$126.95 - $142.14 $107,653 - $120,534
-848 Reduced 1.47%
56,806 $7.35 Million
Q2 2019

Aug 09, 2019

SELL
$131.15 - $144.24 $271,480 - $298,576
-2,070 Reduced 3.47%
57,654 $8.03 Million
Q1 2019

May 13, 2019

SELL
$125.72 - $139.79 $587,489 - $653,238
-4,673 Reduced 7.26%
59,724 $8.35 Million
Q4 2018

Feb 13, 2019

SELL
$122.84 - $147.84 $114,855 - $138,230
-935 Reduced 1.43%
64,397 $8.32 Million
Q3 2018

Nov 05, 2018

BUY
$121.58 - $142.88 $42,188 - $49,579
347 Added 0.53%
65,332 $9.03 Million
Q2 2018

Aug 13, 2018

SELL
$119.4 - $131.76 $37,252 - $41,109
-312 Reduced 0.48%
64,985 $7.89 Million
Q1 2018

May 09, 2018

SELL
$125.1 - $148.14 $257,956 - $305,464
-2,062 Reduced 3.06%
65,297 $8.37 Million
Q4 2017

Feb 07, 2018

SELL
$131.22 - $143.62 $94,872 - $103,837
-723 Reduced 1.06%
67,359 $9.41 Million
Q3 2017

Nov 08, 2017

BUY
$129.47 - $135.38 $8.81 Million - $9.22 Million
68,082
68,082 $8.85 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $404B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Pro Vise Management Group, LLC Portfolio

Follow Pro Vise Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Vise Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Vise Management Group, LLC with notifications on news.